Yahoo Malaysia Web Search

Sign In

Search results

  1. www.abbvie.com › who-we-are › our-storiesOur Stories | AbbVie

    Jun 20, 2024 · Three factors that drove the transformational integration of AbbVie, Allergan. Here’s how we brought together two diverse businesses and groups of people to build a new, stronger company

    • Partnerships

      AbbVie discovers and delivers innovative medicines and...

    • Science

      At AbbVie, our R&D teams are chasing bold goals. We are...

    • Oncology

      We focus on creating targeted medicines that either impede...

    • Company

      Three factors that drove the transformational integration of...

    • Neuroscience

      Over the last 30 years, AbbVie scientists and clinicians...

    • Profile

      Explore the unique career path of Allergan Aesthetics' VP of...

    • Eye Care

      Blindness and vision loss impact over 1 billion people...

  2. Images

    • AbbVie-Allergan Merger Gets Final Clearance in Europe | 2020-03-11 ...
    • Allergan, an AbbVie company | OWL Cary, NC | OWL

    View all

  3. news.abbvie.com › 2024/06/27-Introducing-Alle-Payment-PlansIntroducing Allē Payment Plans, Powered by Cherry

    Jun 27, 2024 · Allē Members Enjoy the Aesthetic Treatments They Love Today, and Pay Over-Time with No Hard Credit Checks. Participation Comes at No Cost* to Aesthetic Providers for Allergan Aesthetics Treatments and Products, Increasing Affordability of Treatments with Flexible Payment Options. IRVINE, Calif., June 27, 2024 / PRNewswire / -- Allergan ...

  4. news.abbvie.com › 2024/06/25-AbbVie-Provides-U-S-RegulatoryAbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa...

    Jun 25, 2024 · ABBV-951 (foscarbidopa/foslevodopa) is a solution of carbidopa and levodopa prodrugs for 24-hour continuous subcutaneous infusion for the treatment of motor fluctuations in adults with advanced Parkinson's disease. ABBV-951 has been approved in 34 countries and over 2,100 patients worldwide have started treatment.

  5. Videos

    View all

  6. www.marketscreener.com › quote › stockAbbVie - Introducing Alle Payment Plans, Powered by Cherry

    Jun 28, 2024 · IRVINE - Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today debuted All Payment Plans, powered by Cherry. By giving consumers the power to pay over-time for aesthetic treatments and products, including BOTOX Cosmetic (onabotulinumtoxinA) and the JUVEDERM Collection of Fillers, All Payment Plans make aesthetics more accessible and ...

  7. www.morningstar.com › stocks › xnysABBV - AbbVie Stock Price Quote - NYSE: ABBV | Morningstar

    3 days ago · AbbVie stock price quote (NYSE: ABBV), historical charts, related news, stock analyst insights and more to help you make the right investing decisions.

  8. news.abbvie.com › 2024/06/11-BOTOX-R-Cosmetic-onabotulinumBOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women...

    Jun 11, 2024 · IRVINE, Calif., June 11, 2024 / PRNewswire / -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV) revealed this year's 20 BOTOX ® Cosmetic grant recipients. Each inspiring woman entrepreneur will receive a $25,000 grant, mentorship, and access to community through the BOTOX ® Cosmetic grant program in partnership with IFundWomen.

  9. www.globenewswire.com › news-release › 2024/06/13Cystic Fibrosis Devices Global Strategic Business Report -...

    Jun 13, 2024 · Company Profiles: Coverage of major players such as AbbVie, Allergan Plc, AstraZeneca, and more.